Hartog J M, Saxena P R, Verdouw P D
Eur Heart J. 1986 Dec;7(12):1067-76. doi: 10.1093/oxfordjournals.eurheartj.a062017.
Intravenous infusion of amrinone at increasing rates (10-100 micrograms kg-1 min-1, N = 8) caused dose dependent decreases in left ventricular filling pressure (up to 22%, P less than 0.05) and cardiac output (up to 16%, P less than 0.05), but had no effect on heart rate, max LVdP/dt or total systemic vascular resistance in anaesthetized open-chest pigs. Despite unchanged total systemic vascular resistance, tissue vascular resistance decreased significantly in the heart, stomach, adrenals and kidneys. Although transmural left ventricular perfusion was not influenced by amrinone, coronary blood flow was redistributed in favour of the epicardium, as endo-epi blood flow ratio decreased from 0.95 +/- 0.03 to 0.82 +/- 0.03 (P less than 0.05). In the same model an intravenous bolus of 1 mg kg-1, followed by a continuous infusion of 50 micrograms kg-1 min-1 (N = 8), caused immediate changes (P less than 0.05) in left ventricular filling pressure (-35%), max LVdP/dt (+55%), heart rate (+15%) and total systemic vascular resistance (-15%). The changes in filling pressure and systemic vascular resistance persisted during the next 25 minutes, but maxLVdP/dt returned gradually to baseline in spite of increasing plasma concentrations of the drug. In the conscious pig (N = 4), administration of a 1 mg kg-1 bolus in the pulmonary artery led to similar increases in heart rate (15%) and max LVdP/dt (26%), while systolic left ventricular pressure was not affected. Direct infusion into the left anterior descending coronary artery (10-40 micrograms kg-1 min-1, N = 5) had negligible effects on overall haemodynamics and regional myocardial function. The only significant changes were a vasodilation in the coronary vascular bed accompanied by dose dependent increases in the coronary venous O2-content. From our study it appears that a bolus injection, as given in the clinical setting, is required to elicit an increase in max LVdP/dt and arterial vasodilation but that the effect on left ventricular preload is not sensitive to different modes of administration.
以递增速率(10 - 100微克/千克·分钟,N = 8)静脉输注氨力农,可使麻醉开胸猪的左心室充盈压呈剂量依赖性降低(降低幅度达22%,P < 0.05)和心输出量降低(降低幅度达16%,P < 0.05),但对心率、左心室最大dp/dt或总体循环血管阻力无影响。尽管总体循环血管阻力未变,但心脏、胃、肾上腺和肾脏的组织血管阻力显著降低。虽然氨力农不影响左心室跨壁灌注,但冠状动脉血流重新分布,有利于心外膜,因为内膜 - 外膜血流比值从0.95±0.03降至0.82±0.03(P < 0.05)。在同一模型中,静脉推注1毫克/千克,随后以50微克/千克·分钟的速度持续输注(N = 8),可使左心室充盈压(-35%)、左心室最大dp/dt(+55%)、心率(+15%)和总体循环血管阻力(-15%)立即发生变化(P < 0.05)。充盈压和体循环血管阻力的变化在接下来的25分钟内持续存在,但尽管药物血浆浓度升高,左心室最大dp/dt仍逐渐恢复至基线水平。在清醒猪(N = 4)中,在肺动脉内推注1毫克/千克可使心率(15%)和左心室最大dp/dt(26%)出现类似升高,而左心室收缩压未受影响。直接向左前降支冠状动脉内输注(10 - 40微克/千克·分钟,N = 5)对整体血流动力学和局部心肌功能的影响可忽略不计。唯一显著的变化是冠状动脉血管床血管舒张,同时冠状动脉静脉氧含量呈剂量依赖性增加。从我们的研究来看,临床应用时似乎需要推注才能引起左心室最大dp/dt升高和动脉血管舒张,但对左心室前负荷的影响对不同给药方式不敏感。